Center for Substance Abuse Prevention; Notice of Meeting, 38355-38356 [2013-15230]

Download as PDF Federal Register / Vol. 78, No. 123 / Wednesday, June 26, 2013 / Notices This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Resource Center: Translational/Developmental Proteomics. Date: July 10–12, 2013. Time: 6:00 p.m. to 12:00 p.m. Contact Person: To review and evaluate grant applications. Place: Avenue Hotel Chicago, 160 E. Huron Street, Chicago, IL 60611. Contact Person: Vonda K Smith, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6188, MSC 7892, Bethesda, MD 20892, 301–435– 1789, smithvo@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 20, 2013. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–15199 Filed 6–25–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES National Cancer Institute Amended; Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, July 08, 2013, 12:00 p.m. to July 08, 2013, 02:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, 7W030, Rockville, MD, 20850 which was published in the Federal Register on May 23, 2013, 78FR30933. The meeting notice is amended to change the meeting room, date and time of the meeting to Room 7W110, July 24, 2013, 1:00 p.m.–2:30 p.m. The meeting is being held as a teleconference. The meeting is closed to the public. Dated: June 20, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–15200 Filed 6–25–13; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 20:26 Jun 25, 2013 Jkt 229001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI National Clinical Trials Network. Date: July 19, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Peter J. Wirth, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9606 Medical Center Drive, 7W514, MSC 9750, Bethesda, MD 20892–9750, 240–276– 6434, pw2q@nih.gov. Name of Committee: National Cancer Institute Initial Review Group Subcommittee A—Cancer Centers. Date: August 8–9, 2013. Time: 8:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Gail J. Bryant, M.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9606 Medical Center Drive, 7W114, MSC 9750, Bethesda, MD 20892– 9750, 240–276–6346, gb30t@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 38355 Dated: June 20, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–15201 Filed 6–25–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, July 23, 2013, 10:00 a.m. to July 23, 2013, 04:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 5W030, Rockville, MD, 20850 which was published in the Federal Register on May 23, 2013, 78FR30933. The meeting notice is amended to change the start time and meeting room from 10:00 a.m. to 4:00 p.m., Room 5W030 to 9:00 a.m. to 4:00 p.m., Room 2W904 on July 23, 2013. The meeting is being held as a teleconference. The meeting is closed to the public. Dated: June 20, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–15202 Filed 6–25–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet on July 15, 2013, from 9:00 a.m. to 4:30 p.m.; July 16, 2013, from 9:00 a.m. to 4:00 p.m.; and July 17, 2013, from 9:00 a.m. to 2:00 p.m. E.D.T. The DTAB will convene in both open and closed sessions over these three days. On July 15, 2013, from 9:00 a.m. to 4:30 p.m., the meeting will be open to the public. The meeting will include updates on the previously announced DTAB recommendations, the Federal Custody and Control Form, the DTAB’s process for evaluating the scientific E:\FR\FM\26JNN1.SGM 26JNN1 38356 Federal Register / Vol. 78, No. 123 / Wednesday, June 26, 2013 / Notices mstockstill on DSK4VPTVN1PROD with NOTICES supportability of the hair specimen for federal workplace drug testing, a historical perspective of hair as a drug testing matrix, and the current perspective of the hair specimen drug testing, including specimen characteristics, collection, preparation, and stability; drug analytes, analyte stability, and analyte cutoffs; initial and confirmatory testing methodologies; proficiency testing; best practices experiences; and hair drug testing data. The public is invited to attend the open session in person or to listen via web conference. Due to the limited seating space and call-in capacity, registration is requested. Public comments are welcome. To register, make arrangements to attend, obtain the web conference call-in numbers and access codes, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register at the SAMHSA Advisory Committees Web site at https://nac.samhsa.gov/ Registration/meetingsRegistration.aspx or contact the CSAP DTAB Designated Federal Official, Dr. Janine Denis Cook (see contact information below). On July 16, 2013, from 9:00 a.m. to 4:00 p.m. and July 17, 2013, from 9:00 a.m. to 2:00 p.m., the Board will meet in closed session to discuss proposed revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs. Therefore, this portion of the meeting is closed to the public as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d). Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees Web site, https:// www.nac.samhsa.gov/DTAB/ meetings.aspx, or by contacting Dr. Cook. Committee Name: Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Prevention Drug Testing Advisory Board. Dates/Time/Type: July 15, 2013, from 9:00 a.m. to 4:30 p.m. E.D.T.: Open. July 16, 2013, from 9:00 a.m. to 4:00 p.m. E.D.T.: Closed. July 17, 2013, from 9:00 a.m. to 2:00 p.m. E.D.T.: Closed. Place: Seneca and Rock Creek Conference Rooms, SAMHSA Office Building, 1 Choke Cherry Road, Rockville, Maryland 20857. Contact: Janine Denis Cook, Ph.D., Designated Federal Official, CSAP Drug Testing Advisory Board, 1 Choke Cherry Road, Room 7–1043, Rockville, Maryland 20857, Telephone: 240–276–2600, Fax: 240– VerDate Mar<15>2010 20:26 Jun 25, 2013 Jkt 229001 276–2610, Email: janine.cook@samhsa.hhs.gov. Janine Denis Cook, Designated Federal Official, DTAB, Division of Workplace Programs, Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration. [FR Doc. 2013–15230 Filed 6–25–13; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5684–N–04] 60-Day Notice of Proposed Information Collection: Notice of Proposed Information Collection for Disaster Recovery Grant Reporting System; Public Comment Request Office of the Assistant Secretary for Community Planning and Development, HUD. ACTION: Notice. AGENCY: HUD is seeking approval from the Office of Management and Budget (OMB) for the information collection described below. In accordance with the Paperwork Reduction Act, HUD is requesting comment from all interested parties on the proposed collection of information. The purpose of this notice is to allow for 60 days of public comment. SUMMARY: DATES: Comments Due Date: August 26, 2013. Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB Control Number and should be sent to: LaRuth Harper, Department of Housing and Urban Development, 451 7th Street SW., Room 7233, Washington, DC 20410. Persons with hearing or speech impairments may access this number through TTY by calling the toll-free Federal Relay Service at (800) 877–8339. FOR FURTHER INFORMATION CONTACT: Stanley Gimont, Director, Office of Block Grant Assistance at (202) 708– 3587. This is not a toll-free number. Persons with hearing or speech impairments may access this number through TTY by calling the toll-free Federal Relay Service at (800) 877–8339. SUPPLEMENTARY INFORMATION: The Department will submit the proposed information collection to OMB for review, as required by the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35 as Amended). This Notice is soliciting comments from members of the public and affected ADDRESSES: PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 agencies concerning the proposed collection of information to: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information; (3) enhance the quality, utility, and clarity of the information to be collected; and (4) minimize the burden of the collection of information on those who are to respond; including through the use of appropriate automated collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. This Notice also lists the following information: A. Overview of Information Collection Title of Information Collection: Disaster Recovery Grant Reporting System—Revision to add Hurricane Sandy and other Disaster Grants. OMB Approval Number: 2506–0165. Type of Request: Revision of a currently approved collection. Form Number: SF–424 Application for Federal Assistance. Description of the need for the information and proposed use: The Disaster Recovery Grant Reporting (DRGR) System is a grants management system used by the Office of Community Planning and Development to monitor special appropriation grants under the Community Development Block Grant program. This collection pertains to Community Development Block Grant Disaster Recovery (CDBG–DR) and Neighborhood Stabilization Program (NSP) grant appropriations. The CDBG program is authorized under Title I of the Housing and Community Development Act of 1974, as amended. Following major disasters, Congress appropriates supplemental CDBG funds for disaster recovery. According to Section 104(e)(1) of the Housing and Community Development Act of 1974, HUD is responsible for reviewing grantees’ compliance with applicable requirements and their continuing capacity to carry out their programs. Grant funds are made available to states and units of general local government, Indian tribes, and insular areas, unless provided otherwise by supplemental appropriations statute, based on their unmet disaster recovery needs. Respondents (i.e. affected public): DRGR is used to monitor CDBG–DR, NSP, and NSP–TA grants, as well as several programs that do not fall under the Office of Block Grant Assistance. E:\FR\FM\26JNN1.SGM 26JNN1

Agencies

[Federal Register Volume 78, Number 123 (Wednesday, June 26, 2013)]
[Notices]
[Pages 38355-38356]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-15230]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet on July 15, 2013, from 9:00 a.m. to 4:30 p.m.; 
July 16, 2013, from 9:00 a.m. to 4:00 p.m.; and July 17, 2013, from 
9:00 a.m. to 2:00 p.m. E.D.T. The DTAB will convene in both open and 
closed sessions over these three days.
    On July 15, 2013, from 9:00 a.m. to 4:30 p.m., the meeting will be 
open to the public. The meeting will include updates on the previously 
announced DTAB recommendations, the Federal Custody and Control Form, 
the DTAB's process for evaluating the scientific

[[Page 38356]]

supportability of the hair specimen for federal workplace drug testing, 
a historical perspective of hair as a drug testing matrix, and the 
current perspective of the hair specimen drug testing, including 
specimen characteristics, collection, preparation, and stability; drug 
analytes, analyte stability, and analyte cutoffs; initial and 
confirmatory testing methodologies; proficiency testing; best practices 
experiences; and hair drug testing data.
    The public is invited to attend the open session in person or to 
listen via web conference. Due to the limited seating space and call-in 
capacity, registration is requested. Public comments are welcome. To 
register, make arrangements to attend, obtain the web conference call-
in numbers and access codes, submit written or brief oral comments, or 
request special accommodations for persons with disabilities, please 
register at the SAMHSA Advisory Committees Web site at https://nac.samhsa.gov/Registration/meetingsRegistration.aspx or contact the 
CSAP DTAB Designated Federal Official, Dr. Janine Denis Cook (see 
contact information below).
    On July 16, 2013, from 9:00 a.m. to 4:00 p.m. and July 17, 2013, 
from 9:00 a.m. to 2:00 p.m., the Board will meet in closed session to 
discuss proposed revisions to the Mandatory Guidelines for Federal 
Workplace Drug Testing Programs. Therefore, this portion of the meeting 
is closed to the public as determined by the Administrator, SAMHSA, in 
accordance with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, Section 
10(d).
    Meeting information and a roster of DTAB members may be obtained by 
accessing the SAMHSA Advisory Committees Web site, https://www.nac.samhsa.gov/DTAB/meetings.aspx, or by contacting Dr. Cook.

    Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention Drug Testing 
Advisory Board.
    Dates/Time/Type: July 15, 2013, from 9:00 a.m. to 4:30 p.m. 
E.D.T.: Open. July 16, 2013, from 9:00 a.m. to 4:00 p.m. E.D.T.: 
Closed. July 17, 2013, from 9:00 a.m. to 2:00 p.m. E.D.T.: Closed.
    Place: Seneca and Rock Creek Conference Rooms, SAMHSA Office 
Building, 1 Choke Cherry Road, Rockville, Maryland 20857.
    Contact: Janine Denis Cook, Ph.D., Designated Federal Official, 
CSAP Drug Testing Advisory Board, 1 Choke Cherry Road, Room 7-1043, 
Rockville, Maryland 20857, Telephone: 240-276-2600, Fax: 240-276-
2610, Email: janine.cook@samhsa.hhs.gov.

Janine Denis Cook,
Designated Federal Official, DTAB, Division of Workplace Programs, 
Center for Substance Abuse Prevention, Substance Abuse and Mental 
Health Services Administration.
[FR Doc. 2013-15230 Filed 6-25-13; 8:45 am]
BILLING CODE 4162-20-P